Global Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Region: Trend Forecast and Growth Opportunity

August 2020 | 170 pages | ID: GF05D509F283EN
GMD Research

Abstracts

Global oncology informatics market will reach $8,602.3 million by 2030, growing by 6.1% annually over 2020-2030 driven by the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates.

Highlighted with 87 tables and 79 figures, this 170-page report “Global Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Electronic Health Records (EHRs)
• Population Health Management (PHM)
• Clinical Decision Support System (CDSS)
• Drug Discovery and Development Informatics (DDDI)
• Data Analytics
• Image Analytics
• Other Product Types

Based on Cancer Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancers

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Medical Application
• Surgical Application
• Radiation Application

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Pharmaceutical Companies
• Life Science Companies
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Electronic Health Records (EHRs)
3.3 Population Health Management (PHM)
3.4 Clinical Decision Support System (CDSS)
3.5 Drug Discovery and Development Informatics (DDDI)
3.6 Data Analytics
3.7 Image Analytics
3.8 Other Product Types

4 SEGMENTATION OF GLOBAL MARKET BY CANCER TYPE

4.1 Market Overview by Cancer Type
4.2 Colorectal Cancer
4.3 Breast Cancer
4.4 Prostate Cancer
4.5 Cervical Cancer

5 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

5.1 Market Overview by Application
5.2 Medical Application
5.3 Surgical Application
5.4 Radiation Application

6 SEGMENTATION OF GLOBAL MARKET BY END USER

6.1 Market Overview by End User
6.2 Pharmaceutical Companies
6.3 Life Science Companies
6.4 Contract Research Organizations (CROs)
6.5 Academic Institutes and Research Centers
6.6 Other End Users

7 SEGMENTATION OF GLOBAL MARKET BY REGION

7.1 Geographic Market Overview 2019-2030
7.2 North America Market 2019-2030 by Country
  7.2.1 Overview of North America Market
  7.2.2 U.S.
  7.2.3 Canada
  7.2.4 Mexico
7.3 European Market 2019-2030 by Country
  7.3.1 Overview of European Market
  7.3.2 Germany
  7.3.3 UK
  7.3.4 France
  7.3.5 Spain
  7.3.6 Italy
  7.3.7 Russia
  7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2019-2030 by Country
  7.4.1 Overview of Asia-Pacific Market
  7.4.2 Japan
  7.4.3 China
  7.4.4 Australia
  7.4.5 India
  7.4.6 South Korea
  7.4.7 Rest of APAC Region
7.5 South America Market 2019-2030 by Country
  7.5.1 Argentina
  7.5.2 Brazil
  7.5.3 Chile
  7.5.4 Rest of South America Market
7.6 MEA Market 2019-2030 by Country
  7.6.1 UAE
  7.6.2 Saudi Arabia
  7.6.3 South Africa
  7.6.4 Other National Markets

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc

9 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Oncology Informatics Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in Global Oncology Informatics Market
Table 3. Global Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 4. Key Products and EHR Vendors
Table 5. Key Products and PHM Vendors
Table 6. Key Products and CDSS Vendors
Table 7. Key Products and DDDI Vendors
Table 8. Global Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 9. Global Oncology Informatics Market by Application, 2019-2030, $ mn
Table 10. Global Oncology Informatics Market by End User, 2019-2030, $ mn
Table 11. Global Oncology Informatics Market by Region, 2019-2030, $ mn
Table 12. Leading National Oncology Informatics Market, 2019 and 2030, $ mn
Table 13. North America Oncology Informatics Market by Country, 2019-2030, $ mn
Table 14. U.S. Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 15. U.S. Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 16. U.S. Oncology Informatics Market by End User, 2019-2030, $ mn
Table 17. Canada Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 18. Canada Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 19. Canada Oncology Informatics Market by End User, 2019-2030, $ mn
Table 20. Mexico Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 21. Mexico Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 22. Mexico Oncology Informatics Market by End User, 2019-2030, $ mn
Table 23. Europe Oncology Informatics Market by Country, 2019-2030, $ mn
Table 24. Germany Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 25. Germany Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 26. Germany Oncology Informatics Market by End User, 2019-2030, $ mn
Table 27. UK Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 28. UK Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 29. UK Oncology Informatics Market by End User, 2019-2030, $ mn
Table 30. France Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 31. France Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 32. France Oncology Informatics Market by End User, 2019-2030, $ mn
Table 33. Spain Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 34. Spain Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 35. Spain Oncology Informatics Market by End User, 2019-2030, $ mn
Table 36. Italy Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 37. Italy Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 38. Italy Oncology Informatics Market by End User, 2019-2030, $ mn
Table 39. Russia Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 40. Russia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 41. Russia Oncology Informatics Market by End User, 2019-2030, $ mn
Table 42. Oncology Informatics Market in Rest of Europe by Country, 2019-2030, $ mn
Table 43. APAC Oncology Informatics Market by Country, 2019-2030, $ mn
Table 44. Japan Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 45. Japan Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 46. Japan Oncology Informatics Market by End User, 2019-2030, $ mn
Table 47. China Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 48. China Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 49. China Oncology Informatics Market by End User, 2019-2030, $ mn
Table 50. Australia Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 51. Australia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 52. Australia Oncology Informatics Market by End User, 2019-2030, $ mn
Table 53. India Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 54. India Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 55. India Oncology Informatics Market by End User, 2019-2030, $ mn
Table 56. South Korea Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 57. South Korea Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 58. South Korea Oncology Informatics Market by End User, 2019-2030, $ mn
Table 59. Oncology Informatics Market in Rest of APAC by Country, 2019-2030, $ mn
Table 60. South America Oncology Informatics Market by Country, 2019-2030, $ mn
Table 61. Argentina Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 62. Argentina Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 63. Argentina Oncology Informatics Market by End User, 2019-2030, $ mn
Table 64. Brazil Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 65. Brazil Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 66. Brazil Oncology Informatics Market by End User, 2019-2030, $ mn
Table 67. Chile Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 68. Chile Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 69. Chile Oncology Informatics Market by End User, 2019-2030, $ mn
Table 70. MEA Oncology Informatics Market by Country, 2019-2030, $ mn
Table 71. UAE Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 72. UAE Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 73. UAE Oncology Informatics Market by End User, 2019-2030, $ mn
Table 74. Saudi Arabia Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 75. Saudi Arabia Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 76. Saudi Arabia Oncology Informatics Market by End User, 2019-2030, $ mn
Table 77. South Africa Oncology Informatics Market by Product Type, 2019-2030, $ mn
Table 78. South Africa Oncology Informatics Market by Cancer Type, 2019-2030, $ mn
Table 79. South Africa Oncology Informatics Market by End User, 2019-2030, $ mn
Table 80. Breakdown of Global Market by Key Vendor, 2019, %
Table 81. Cerner Corporation: Company Snapshot
Table 82. Cerner Corporation: Business Segmentation
Table 83. Cerner Corporation: Product Portfolio
Table 84. Cerner Corporation: Revenue, 2016-2018, $ mn
Table 85. Cerner Corporation: Recent Developments
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030
Table 87. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Oncology Informatics Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Oncology Informatics Market
Figure 8. Primary Restraints and Impact Factors of Global Oncology Informatics Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Global Oncology Informatics Market
Figure 11. Breakdown of Global Oncology Informatics Market by Product Type, 2019-2030, % of Revenue
Figure 12. Global Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)
Figure 13. Global Oncology Informatics Market: Electronic Health Records (EHRs), 2019-2030, $ mn
Figure 14. Global Oncology Informatics Market: Population Health Management (PHM), 2019-2030, $ mn
Figure 15. Global Oncology Informatics Market: Clinical Decision Support System (CDSS), 2019-2030, $ mn
Figure 16. Global Oncology Informatics Market: Drug Discovery and Development Informatics (DDDI), 2019-2030, $ mn
Figure 17. Global Oncology Informatics Market: Data Analytics, 2019-2030, $ mn
Figure 18. Global Oncology Informatics Market: Image Analytics, 2019-2030, $ mn
Figure 19. Global Oncology Informatics Market: Other Product Types, 2019-2030, $ mn
Figure 20. Breakdown of Global Oncology Informatics Market by Cancer Type, 2019-2030, % of Sales Revenue
Figure 21. Global Addressable Market Cap in 2020-2030 by Cancer Type, Value ($ mn) and Share (%)
Figure 22. Global Oncology Informatics Market: Colorectal Cancer, 2019-2030, $ mn
Figure 23. Global Oncology Informatics Market: Breast Cancer, 2019-2030, $ mn
Figure 24. Global Oncology Informatics Market: Prostate Cancer, 2019-2030, $ mn
Figure 25. Global Oncology Informatics Market: Cervical Cancer, 2019-2030, $ mn
Figure 26. Breakdown of Global Oncology Informatics Market by Application, 2019-2030, % of Sales Revenue
Figure 27. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 28. Global Oncology Informatics Market: Medical Application, 2019-2030, $ mn
Figure 29. Global Oncology Informatics Market: Surgical Application, 2019-2030, $ mn
Figure 30. Global Oncology Informatics Market: Radiation Application, 2019-2030, $ mn
Figure 31. Breakdown of Global Oncology Informatics Market by End User, 2019-2030, % of Revenue
Figure 32. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 33. Global Oncology Informatics Market: Pharmaceutical Companies, 2019-2030, $ mn
Figure 34. Global Oncology Informatics Market: Life Science Companies, 2019-2030, $ mn
Figure 35. Global Oncology Informatics Market: Contract Research Organizations (CROs), 2019-2030, $ mn
Figure 36. Global Oncology Informatics Market: Academic Institutes and Research Centers, 2019-2030, $ mn
Figure 37. Global Oncology Informatics Market: Other End Users, 2019-2030, $ mn
Figure 38. Global Market Snapshot by Region
Figure 39. Geographic Spread of Worldwide Oncology Informatics Market, 2019-2030, % of Sales Revenue
Figure 40. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)
Figure 41. North American Oncology Informatics Market, 2019-2030, $ mn
Figure 42. Breakdown of North America Oncology Informatics Market by Country, 2019 and 2030, % of Revenue
Figure 43. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 44. U.S. Oncology Informatics Market, 2019-2030, $ mn
Figure 45. Canada Oncology Informatics Market, 2019-2030, $ mn
Figure 46. Oncology Informatics Market in Mexico, 2015-2030, $ mn
Figure 47. European Oncology Informatics Market, 2019-2030, $ mn
Figure 48. Breakdown of European Oncology Informatics Market by Country, 2019 and 2030, % of Revenue
Figure 49. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 50. Oncology Informatics Market in Germany, 2019-2030, $ mn
Figure 51. Oncology Informatics Market in UK, 2019-2030, $ mn
Figure 52. Oncology Informatics Market in France, 2019-2030, $ mn
Figure 53. Oncology Informatics Market in Spain, 2019-2030, $ mn
Figure 54. Oncology Informatics Market in Italy, 2019-2030, $ mn
Figure 55. Oncology Informatics Market in Russia, 2019-2030, $ mn
Figure 56. Oncology Informatics Market in Rest of Europe, 2019-2030, $ mn
Figure 57. Asia-Pacific Oncology Informatics Market, 2019-2030, $ mn
Figure 58. Breakdown of APAC Oncology Informatics Market by Country, 2019 and 2030, % of Revenue
Figure 59. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 60. Oncology Informatics Market in Japan, 2019-2030, $ mn
Figure 61. Oncology Informatics Market in China, 2019-2030, $ mn
Figure 62. Oncology Informatics Market in Australia, 2019-2030, $ mn
Figure 63. Oncology Informatics Market in India, 2019-2030, $ mn
Figure 64. Oncology Informatics Market in South Korea, 2019-2030, $ mn
Figure 65. Oncology Informatics Market in Rest of APAC, 2019-2030, $ mn
Figure 66. South America Oncology Informatics Market, 2019-2030, $ mn
Figure 67. Breakdown of South America Oncology Informatics Market by Country, 2019 and 2030, % of Revenue
Figure 68. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 69. Oncology Informatics Market in Argentina, 2019-2030, $ mn
Figure 70. Oncology Informatics Market in Brazil, 2019-2030, $ mn
Figure 71. Oncology Informatics Market in Chile, 2019-2030, $ mn
Figure 72. Oncology Informatics Market in Rest of South America, 2019-2030, $ mn
Figure 73. Oncology Informatics Market in Middle East and Africa (MEA), 2019-2030, $ mn
Figure 74. Breakdown of MEA Oncology Informatics Market by Country, 2019 and 2030, % of Revenue
Figure 75. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 76. Oncology Informatics Market in UAE, 2019-2030, $ mn
Figure 77. Oncology Informatics Market in Saudi Arabia, 2019-2030, $ mn
Figure 78. Oncology Informatics Market in South Africa, 2019-2030, $ mn
Figure 79. Growth Stage of Global Oncology Informatics Industry over the Forecast Period


COMPANIES MENTIONED

Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc